Inventor · disambiguated record
Heike Keilhack
Also filed as: KEILHACK HEIKE
32 granted patents·38 pending applications·411 citations·filing 2012–2024
98Inventor score
Top patents by PatentIndex Score
70 records- 0198US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 0298US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 0398US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 0498US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 0597US11642349B2Method for treating cancerEPIZYME INC·Filed 2020·Granted May 9, 2023·4 cites·11 claims
- 0697US11370781B2Combination therapy for treating cancerEPIZYME INC·Filed 2020·Granted Jun 28, 2022·4 cites·20 claims
- 0796US11951109B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2021·Granted Apr 9, 2024·4 cites·14 claims
- 0896US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 0996US10946024B2Method for treating cancerEPIZYME INC·Filed 2019·Granted Mar 16, 2021·7 cites·11 claims
- 1096US10787440B2Combination therapy for treating cancerEPIZYME INC·Filed 2019·Granted Sep 29, 2020·8 cites·20 claims
- 1196US10493076B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Dec 3, 2019·7 cites·22 claims
- 1296US10369155B2Method for treating cancerEPIZYME INC·Filed 2017·Granted Aug 6, 2019·8 cites·20 claims
- 1396US10301290B2Combination therapy for treating cancerEPIZYME INC·Filed 2013·Granted May 28, 2019·13 cites·9 claims
- 1496US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 1596US9889138B2Method for treating cancerEPIZYME INC·Filed 2016·Granted Feb 13, 2018·10 cites·35 claims
- 1696US9855275B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Jan 2, 2018·18 cites·30 claims
- 1796US9688665B2Methods of treating cancerEPIZYME INC·Filed 2013·Granted Jun 27, 2017·23 cites·16 claims
- 1895US11642347B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2020·Granted May 9, 2023·6 cites·10 claims
- 1995US11202781B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2019·Granted Dec 21, 2021·8 cites·14 claims
- 2095US10420775B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Sep 24, 2019·12 cites·20 claims
- 2194US10463671B2Combination therapy for treating cancerEPIZYME INC·Filed 2017·Granted Nov 5, 2019·12 cites·25 claims
- 2293US10456407B2Combination therapy for treating cancerEPIZYME INC·Filed 2016·Granted Oct 29, 2019·11 cites·20 claims
- 2392US12168015B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·2 claims
- 2492US12161645B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 10, 2024·0 cites·10 claims
- 2592US11026949B2Combination therapy for treating cancerEPIZYME INC·Filed 2019·Granted Jun 8, 2021·7 cites·20 claims
- 2691US12168016B2Aryl-OR heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·12 claims
- 2791US10166238B2EZH2 inhibitors for treating lymphomaEPIZYME INC·Filed 2015·Granted Jan 1, 2019·12 cites·19 claims
- 2891US2025170138A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Application pending·0 cites
- 2990US10898490B2Method for treating cancerEPIZYME INC·Filed 2019·Granted Jan 26, 2021·5 cites·11 claims
- 3090US9376422B2Dihidropyridin-2-one benzamine compoundsKUNTZ KEVIN WAYNE·Filed 2012·Granted Jun 28, 2016·16 cites·19 claims
- 3190US2025163033A1Methods of treating cancerEPIZYME INC·Filed 2024·Application pending·0 cites
- 3287US2025109123A1Combination therapy for treating cancerEPIZYME INC·Filed 2024·Application pending·0 cites
- 3386US2025152598A1Method for treating cancerEPIZYME INC·Filed 2024·Application pending·0 cites
- 3483US12162865B2Methods of treating cancerEPIZYME INC·Filed 2022·Granted Dec 10, 2024·0 cites·14 claims
- 3581US10786511B2Method for treating cancerEPIZYME INC·Filed 2015·Granted Sep 29, 2020·5 cites·20 claims
- 3681US2024024331A1Method for treating cancerEPIZYME INC·Filed 2023·Application pending·0 cites
- 3780US2024058348A1Ezh2 inhibitors for treating lymphomaEPIZYME INC·Filed 2023·Application pending·0 cites
- 3879US2024293419A1Combination therapy for treating cancerEPIZYME INC·Filed 2023·Application pending·0 cites
- 3979US2022281854A1Combination therapy for treating cancerEPIZYME INC·Filed 2022·Application pending·0 cites
- 4078US2021379076A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2021·Application pending·0 cites
- 4178US2022218714A1Method of treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 4275US2022226336A1Combination therapy for treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 4374US2025064822A1Method for treating cancerEPIZYME INC·Filed 2024·Application pending·0 cites
- 4473US2021267990A1Method for treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 4571US2020138825A1Method of treating malignant rhabdoid tumor of the ovary (mrto)/small cell cancer of the ovary of the hypercalcemic type(sccoht) with an ezh2 inhibitorEPIZYME INC·Filed 2019·Application pending·0 cites
- 4670US2020262823A1Methods of treating cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 4770US2022160721A1Methods of treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 4870US2020330472A1Method of treating cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 4969US2021353632A1Combination therapy for treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 5066US2021121470A1Method of treating malignant rhabdoid tumor of the ovary (mrto)/small cell cancer of the ovary of the hypercalcemic type(sccoht) with an ezh2 inhibitorEPIZYME INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →